CV Sciences, Inc. (CVSI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2M 4M 6M Q3 '21: 5.1M Q4 '21: 5M Q1 '22: 4.4M Q2 '22: 4.1M Q3 '22: 3.8M Q4 '22: 3.9M Q1 '23: 4.1M Q2 '23: 4M Q3 '23: 4.1M Q4 '23: 3.8M Q1 '24: 4M Q2 '24: 4M Q3 '24: 3.9M Q4 '24: 3.9M Q1 '25: 3.6M Q2 '25: 3.6M Q3 '25: 3.3M Q4 '25: 3.3M Q1 '26: 3.2M Q2 '26: 3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 900K 1.8M 2.7M Q3 '21: 2.4M Q4 '21: 1.6M Q1 '22: 1.2M Q2 '22: 1.3M Q3 '22: 1.6M Q4 '22: 1.6M Q1 '23: 1.8M Q2 '23: 1.7M Q3 '23: 1.8M Q4 '23: 1.7M Q1 '24: 1.9M Q2 '24: 1.9M Q3 '24: 1.8M Q4 '24: 1.7M Q1 '25: 1.7M Q2 '25: 1.8M Q3 '25: 1.6M Q4 '25: 1.7M Q1 '26: 1.6M Q2 '26: 1.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -3M Q4 '21: -8.8M Q1 '22: -1.5M Q2 '22: -2.3M Q3 '22: -892K Q4 '22: -2.1M Q1 '23: 5.8M Q2 '23: -1.1M Q3 '23: -437K Q4 '23: -889K Q1 '24: -620K Q2 '24: -583K Q3 '24: -341K Q4 '24: -646K Q1 '25: 11K Q2 '25: -131K Q3 '25: -275K Q4 '25: -75K Q1 '26: -318K Q2 '26: -301K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -40K Q4 '21: -8.9M Q1 '22: -2.2M Q2 '22: -2.7M Q3 '22: -1M Q4 '22: -2.3M Q1 '23: 5.7M Q2 '23: -1.3M Q3 '23: -447K Q4 '23: -869K Q1 '24: -628K Q2 '24: -584K Q3 '24: -456K Q4 '24: -726K Q1 '25: -109K Q2 '25: -261K Q3 '25: -382K Q4 '25: -206K Q1 '26: -643K Q2 '26: -775K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '21: 2.7M Q4 '21: 3.4M Q1 '22: 3.3M Q2 '22: 2.9M Q3 '22: 2.2M Q4 '22: 2.3M Q1 '23: 2.4M Q2 '23: 2.2M Q3 '23: 2.2M Q4 '23: 2.1M Q1 '24: 2.1M Q2 '24: 2.1M Q3 '24: 2.1M Q4 '24: 2.2M Q1 '25: 1.9M Q2 '25: 1.8M Q3 '25: 1.7M Q4 '25: 1.6M Q1 '26: 1.6M Q2 '26: 1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -1.6M Q4 '21: -1.2M Q1 '22: -379K Q2 '22: -1.2M Q3 '22: -547K Q4 '22: 210K Q1 '23: 975K Q2 '23: 1.4M Q3 '23: -19K Q4 '23: -114K Q1 '24: -518K Q2 '24: -57K Q3 '24: -122K Q4 '24: -164K Q1 '25: -81K Q2 '25: 287K Q3 '25: -259K Q4 '25: -354K Q1 '26: 101K Q2 '26: 20K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '20: -2M Q4 '20: -1.7M Q1 '21: -1.7M Q2 '21: -3.1M Q3 '21: -1.6M Q4 '21: -1.2M Q1 '22: -379K Q2 '22: -1.2M Q3 '22: -547K Q4 '22: 210K Q1 '24: -518K Q2 '24: -57K Q3 '24: -122K Q4 '24: -182K Q1 '25: -121K Q2 '25: 238K Q3 '25: -270K Q4 '25: -363K Q1 '26: 98K Q2 '26: 13K Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q3 '19: 98.7M Q2 '20: 99.9M Q3 '20: 100M Q1 '21: 104.5M Q2 '21: 107.6M Q3 '21: 109.1M Q1 '22: 116.8M Q2 '22: 135.4M Q3 '22: 146.5M Q1 '23: 152.1M Q2 '23: 152.6M Q3 '23: 154.6M Q1 '24: 163.1M Q2 '24: 172.4M Q3 '24: 182.3M Q1 '25: 184.3M Q2 '25: 184.3M Q3 '25: 184.3M Q1 '26: 186.9M Q2 '26: 205.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.18 -0.12 -0.06 0.00 0.06 0.12 0.18 Q3 '21: -0.15 Q4 '21: -0.14 Q1 '22: -0.13 Q2 '22: -0.13 Q3 '22: -0.14 Q4 '22: -0.08 Q1 '23: -0.02 Q2 '23: -0.00 Q3 '23: 0.01 Q4 '23: 0.02 Q1 '24: -0.02 Q2 '24: -0.01 Q3 '24: -0.01 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: -0.01 Q1 '26: -0.01 Q2 '26: -0.01 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.